[1]
“Risperidone versus quetiapine: risk of developing metabolic syndromes in patients suffering from psychiatry disorders of a health care center”, AJPHS, vol. 10, no. 3, pp. 2309–2317, Sep. 2020, Accessed: Apr. 21, 2026. [Online]. Available: https://www.ajphs.com/index.php/ajphs/article/view/602